Most of the study participants, 306/425 (72.0%) had severe anemia; Hb value of <80 g/L (<8 g/dL), and 96.7% of the total patients had co-morbidity associated with the reason to transfusion (Table 1). The gene discussed is GSTM1; the disease is anemia (phenotype).